Magnetic helmet trial aims to slow deadly brain tumors
Disease control
Recruiting now
This pilot trial tests a portable, wearable device that delivers low-intensity magnetic therapy to people with newly diagnosed glioblastoma, an aggressive brain cancer. The study will enroll 30 adults who have had surgery and are able to receive standard radiotherapy. The main go…
Phase: NA • Sponsor: BioTex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC